- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06952569
Human Factors Validation and Usability Testing of the IKE Age-Gating System
Age-Gate Validation Functionality Testing of the IKE Application
Study Overview
Detailed Description
Study Objectives:
IKE developed a smartphone application which identifies and age-verifies users and works in conjunction with a Bluetooth low energy (BLE) chip to restrict connecting to and activating a device by a users age. The intention is to use this in ENDs devices, and therefore the age limit was set to 21 years. This feature is generally referred to as "age-gating."
The purpose of the study is to:
- Generally establish the ability of individuals to successfully download and use the IKE application
- Confirm the identification and age-verification application works effectively to prevent those under 21 from enabling the IKE application
- Confirm the identification and age-verification application works effectively to allow those 21 years of age or older to enable the IKE application
- Establish that only individual over 21 years of age is able to connect a device to the IKE application via Bluetooth
Upon successful Bluetooth connection to the device via the IKE application:
- Confirm the Maximum Idle Time function works by disconnecting the device and powering the device off within a maximum of 15 minutes
- Confirm the Out of Bluetooth Range function works specific to connection of the Vape device to the smartphone (Vape device will be placed in Faraday bag to force disconnect from smartphone) and the user can re-activate the device
- Confirm users are able to reactivate the same device after either Maximum Idle Time disconnect or Out of Bluetooth Range disconnect
Establish the ability of an identity and age-verified individual to log-in to the application on a secondary device (in this case a tablet) and effectively connect the device using Bluetooth while simultaneously forcing disconnection of the previously connected device
Further, the research is designed to have participants use the smartphone application in as natural as possible setting without direct instruction to simulate a real-world use setting.
Study Type
Enrollment (Actual)
Contacts and Locations
Study Locations
-
-
California
-
Los Angeles, California, United States, 90024
- Alder Weiner, MARC Research facility partner
-
-
Illinois
-
Chicago, Illinois, United States, 60611
- Focus Center, MARC Research facility partner
-
-
New York
-
New York, New York, United States, 10036
- L&E Research, MARC Research facility partner
-
-
Texas
-
Houston, Texas, United States, 77477
- Creative Consumer Research, MARC Research facility partner
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Sampling Method
Study Population
Description
Inclusion Criteria:
- Currently live in proximity to one of the four central location sites
- Ages 18 and older
- Have a valid driver's license or US government-issued identification with picture
- Currently use a smartphone with an iOS (Apple) or Android operating system
- Indicate somewhat (3), very (4), or extremely (5) comfortable using smartphone applications on intake questionnaire
- Able and willing to comply with all study requirements
- Review and sign informed consent
Exclusion Criteria:
- Under 18 years of age
- Among 21-64 years of age, do not currently use cigarettes or vape products
- Do not own or use a smartphone with an iOS (Apple) or Android operating system
- Unable to download any smartphone application
- Employees of or household member employed in advertising/marketing, market research, healthcare, legal field, news and media, or local, state or US Federal government to minimize bias and to protect any proprietary product information that will be disclosed in the study
Study Plan
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
|---|---|
|
Age 18-20, non user
|
Age-gate the access and activation of a device to authorized users of legal age
Other Names:
|
|
Age 21-24, Smoker, Vape user or Both
|
Age-gate the access and activation of a device to authorized users of legal age
Other Names:
|
|
Age 22-44, Smoker, Vape user or Both
|
Age-gate the access and activation of a device to authorized users of legal age
Other Names:
|
|
Age 45-64, Smoker, Vape user or Both
|
Age-gate the access and activation of a device to authorized users of legal age
Other Names:
|
|
Age 65 or older, Smoker, Vape user or Both
|
Age-gate the access and activation of a device to authorized users of legal age
Other Names:
|
|
Age 65 or older, Non-user
|
Age-gate the access and activation of a device to authorized users of legal age
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Accurately age-verify users using a government ID and live photo
Time Frame: Day 1
|
Error rate
|
Day 1
|
|
Prevents users under 21 year of age from enabling IKE application
Time Frame: Day 1
|
Pass or Fail
|
Day 1
|
|
Allows users age 21 and older to enable IKE application
Time Frame: Day 1
|
Pass or Fail
|
Day 1
|
|
IKE application connects to and activates a device for users over 21 years of age
Time Frame: Day 1
|
Pass or Fail
|
Day 1
|
|
Users are able to download the IKE application
Time Frame: Day 1
|
Task completion Error rate
|
Day 1
|
|
Device disconnects and powers off within 15 minutes of idling (no use)
Time Frame: Day 1
|
Pass or Fail
|
Day 1
|
|
Device is disconnected and powered off after losing Bluetooth signal
Time Frame: Day 1
|
Pass or Fail
|
Day 1
|
|
User is able to reactivate the device after being disconnected and powered off
Time Frame: Day 1
|
Task completion
|
Day 1
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
User download the IKE application on personal smartphone
Time Frame: Day 1
|
Error rate
|
Day 1
|
|
Perceived Ease of IKE Application Account Setup
Time Frame: Day 1
|
Extremely Easy (1), Very Easy (2), Somewhat Easy (3), Not very easy (4), Not at all easy (5)
|
Day 1
|
|
Accurately identifies age, race/ethnicity, and gender
Time Frame: Day 1
|
Error rate
|
Day 1
|
Collaborators and Investigators
Sponsor
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Other Study ID Numbers
- Pro00083344
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
product manufactured in and exported from the U.S.
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Vaping
-
University of British ColumbiaUniversité de Sherbrooke; University of Alberta; McMaster University; University... and other collaboratorsRecruitingVaping | Small Airways Diseases | Vaping Teens | Vaping Related Disorder | Vaping BehaviorCanada
-
Philip Morris Products S.A.CompletedNicotine | Nicotine Vaping | VapingUnited Kingdom
-
University of Ontario Institute of TechnologyThe University of Texas Health Science Center, Houston; University of Waterloo and other collaboratorsActive, not recruiting
-
Yale UniversityNational Cancer Institute (NCI)Recruiting
-
Alexandria UniversityCompleted
-
National Institute on Drug Abuse (NIDA)TerminatedHealthy Volunteers | Vaping TeensUnited States
-
National Institute on Drug Abuse (NIDA)TerminatedHealthy Volunteers | Vaping TeensUnited States
-
UNC Lineberger Comprehensive Cancer CenterNational Institute on Drug Abuse (NIDA)Completed
-
St. Jude Children's Research HospitalActive, not recruitingVaping | Vaping CessationUnited States
-
Yale UniversityNational Institute on Drug Abuse (NIDA); American University of Beirut Medical...CompletedNicotine VapingUnited States
Clinical Trials on IKE System
-
University of HawaiiNational Institute on Minority Health and Health Disparities (NIMHD)Completed
-
ResMedCompleted
-
Federal University of São PauloCompletedAdverse Reaction to Systemic AgentsBrazil
-
KineticureCompletedOsteoarthritis | Knee PainUnited States
-
Boston Scientific CorporationRecruitingRenal Calculi | Calculi, Urinary | Ureteral Stones, Kidney Stones | Benign Prostate Hypertrophy(BPH) | Urinary Tract ProcedureUnited States
-
Baskent UniversityHacettepe UniversityCompletedProsthesis User | Artificial Limbs | AmputeesTurkey
-
C. R. BardCompletedVascular Access ComplicationsUnited States
-
University of Missouri-ColumbiaTyco Healthcare GroupCompleted